Abstract
Radiotherapy remains a key component of modern multimodal anticancer treatment approaches. Although most clinically relevant improvements in radiation oncology are based on optimized radiation technology, it now becomes obvious that biology-based approaches will further boost the efficacy of modern radiation oncology. Of relevance to this is the question of the ultimate fate of an irradiated cell and the mechanistic basis of the induced cell death or inactivation observed. Research bearing on this question is reported in this issue of Oncogene by Wendt et al. (2005), who show that the levels of p21CIP/WAF1 play a key role in determining whether an irradiated tumour cell is arrested in the G2 phase of the cell cycle, rather than apoptosing. The demonstration that caffeine treatment can abrogate this G2 arrest, and that the cells go on to die, has implications for overcoming treatment resistance imposed by radiation-induced upregulation of p21CIP/WAF1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, Budach W . (2004). Int J Radiat Oncol Biol Phys 58: 542–554.
Castedo M, Perfettini JL, Roumier T, Valent A, Raslova H, Yakushijin K et al. (2004a). Oncogene 23: 4362–4370.
Castedo M, Perfettini JL, Roumier T, Yakushijin K, Horne D, Medema R et al. (2004b). Oncogene 23: 4353–4361.
El-Deiry WS . (2003). Oncogene 22: 7486–7495.
Iliakis G, Wang Y, Guan J, Wang H . (2003). Oncogene 22: 5834–5847.
Rau B, Sturm I, Lage H, Berger S, Schneider U, Hauptmann S et al. (2003). J Clin Oncol 21: 3391–3401.
Seoane J, Le HV, Massague J . (2002). Nature 419: 729–734.
Sturm I, Petrowsky H, Volz R, Lorenz M, Radetzki S, Hillebrand T et al. (2001). J Clin Oncol 19: 2272–2281.
Wendt J, Radetzki S, von Haefen C, Hemmati PG, Güner D, Schulze-Osthoff K et al. (2005). Oncogene (In press).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Belka, C. The fate of irradiated tumor cells. Oncogene 25, 969–971 (2006). https://doi.org/10.1038/sj.onc.1209175
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209175
Keywords
This article is cited by
-
Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341)
Archives of Gynecology and Obstetrics (2009)
-
Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy
Breast Cancer Research and Treatment (2009)
-
Radiobiologic response of medulloblastoma cell lines: involvement of β-catenin?
Journal of Neuro-Oncology (2008)